Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K2 | P36507 | 2/20 | 0.42 |
| ▸ | MAP2K1 | Q02750 | 2/20 | 0.42 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TYMS | P04818 | 2/20 | 0.40 |
| ▸ | EGFR | P00533 | 1/20 | 0.40 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.40 |
| ▸ | RHEB | Q15382 | 1/20 | 0.39 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.37 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.37 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.37 |
| ▸ | G6PD | P11413 | 1/20 | 0.37 |
| ▸ | CCR6 | P51684 | 1/20 | 0.37 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30548745 | 0.85 | MAP2K2 (0.48) | MAP2K2MAP2K1HAO1LMNASMN1; SMN2 | |
| SCHEMBL30832956 | 0.78 | LMNA (0.57) | MAP2K2MAP2K1HAO1LMNASMN1; SMN2 | |
| SCHEMBL761802 | 0.78 | LMNA (0.57) | MAP2K2MAP2K1HAO1LMNASMN1; SMN2 | |
| SCHEMBL3609852 | 0.76 | TUBB4A (0.45) | LMNASMN1; SMN2SIRT1ALDH1A1HSD17B10 | |
| SCHEMBL12952450 | 0.75 | LMNA (0.47) | MAP2K2MAP2K1HAO1LMNASMN1; SMN2 | |
| SCHEMBL8006473 | 0.75 | MEN1 (0.33) | SMN1; SMN2RHEBCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL23674203 | 0.73 | SMN1; SMN2 (0.50) | HAO1LMNASMN1; SMN2RHEBCYP2A6 | |
| SCHEMBL20222310 | 0.73 | CYP1A2 (0.46) | HAO1LMNASMN1; SMN2TYMSEGFR | |
| SCHEMBL29923079 | 0.73 | SMN1; SMN2 (0.50) | HAO1LMNASMN1; SMN2RHEBCYP2A6 | |
| SCHEMBL29923046 | 0.73 | RHEB (0.55) | LMNARHEBCYP1A2ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10693077-B2 | Compound and organic electronic device using the same | SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) | 2020-06-23 | — | — | US | disclosed |
| US-20190092745-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2019-03-28 | — | — | US | disclosed |
| US-20180155312-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2018-06-07 | — | — | US | disclosed |
| US-20180155312-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2018-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190092745-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | SCO2, AOX1, ORC3 | MAP2K2 450/4885MAP2K1 347/4885HAO1 732/4885 |
| US-10693077-B2 | Compound and organic electronic device using the same | SOD1, SCO2, RCOR3 | MAP2K2 942/4885MAP2K1 650/4885HAO1 1100/4885 |
| US-20180155312-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | SOD1, SCO2, RCOR3 | MAP2K2 942/4885MAP2K1 650/4885HAO1 1100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.